MSM Osteoarthritis Randomized Trial: What the Evidence Says

Quick Answer

MSM Osteoarthritis Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• LE is characterized by chronic lateral elbow pain, which is typically defined as symptoms persisting for more than 3 months, along with reduced grip strength and functional limitations that substantially affect daily and occupational activities. [Park Jun-Ho (2026); evidence level 2]
• Persistent pain often limits daily and occupational functioning and is frequently associated with psychological distress, including anxiety, kinesiophobia, and fear-avoidance behaviors. [Park Jun-Ho (2026); evidence level 2]
• However, their clinical utility has been limited by significant long-term risks: systematic reviews have shown that single injections provide analgesia for 6 weeks, but repeated administrations can induce plantar fascia matrix degradation, increasing the risk of structural injuries such as fat pad atrophy and full-thickness tears. [Zhong Minghua (2026); evidence level 2]
• Despite growing clinical use in plantar fasciitis, evidence remains scarce, primarily consisting of case reports or small observational studies lacking direct comparisons with corticosteroids and long-term follow-up data. [Zhong Minghua (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For MSM osteoarthritis randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Park Jun-Ho (2026). Effects of Blood Flow Restriction Training Combined With Conventional Physical Therapy on Pain, Muscle Architecture, Strength, Function, and Psychosocial Outcomes in Chronic Lateral Epicondylitis: A Pilot Randomized Controlled Trial. DOI: 10.12659/MSM.951969. PMCID: PMC12951797. PMID: 41736376. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12951797/
• Zhong Minghua (2026). Ultrasound-Guided Zhengqing Fengtongning vs Corticosteroid Injections for Plantar Fasciitis: A Randomized Controlled Trial on Short- and Long-Term Efficacy. DOI: 10.12659/MSM.950455. PMCID: PMC12874898. PMID: 41620820. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12874898/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.